Review of feline pancreatitis part two: Clinical signs, diagnosis and treatment

Journal of Feline Medicine and Surgery

Volumn 3, Issue 3, 2001, Pages 125-132

  Mansfield, C S ^a   Jones, B R ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; INSULIN; NITRIC OXIDE; ORAL ANTIDIABETIC AGENT; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ABDOMINAL DISEASE; ACUTE DISEASE; ACUTE PANCREATITIS; ANIMAL; ANIMAL DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; CAT; CAT DISEASE; CHOLANGITIS; CHRONIC DISEASE; CHRONIC PANCREATITIS; CLINICAL FEATURE; COMMON BILE DUCT OBSTRUCTION; COMPLICATION; DIABETES MELLITUS; DISEASE ASSOCIATION; DOG; ENTERITIS; HEPATITIS; JEJUNOSTOMY; NONHUMAN; PANCREAS ABSCESS; PANCREAS PSEUDOCYST; PANCREATITIS; PERCUTANEOUS DRAINAGE; REVIEW; SPECIES DIFFERENCE; SURGEON; VETERINARY MEDICINE;

CANIS FAMILIARIS; FELIDAE; FELIS CATUS;

EID: 0035173826     PISSN: 1098612X     EISSN: None     Source Type: Journal    
DOI: 10.1053/jfms.2001.0130     Document Type: Review

References (68)

1. Acute pancreatitis in cats with hepatic lipidosis
2. Activation peptide of carboxypeptidase B in serum and urine in acute pancreatitis
3. Urinary trypsinogen activation peptides (TAP) are not increased in mild ERCP-induced pancreatitis
4. Acinar cell carcinoma of the pancreas in a cat
5. Cystogastrostomy in the treatment of pancreatic pseudocyst/abscess in two dogs
6. Trypsin-alpha1 -protease inhibitor complexes in serum and clinical course of acute pancreatitis
7. A clinically based classification system for acute pancreatitis
8. High feline trypsin-like immunoreactivity in a cat with pancreatitis and hepatic lipidosis
9. CAPAP in acute pancreatitis: Just another marker or real progress?
10. Proinflammatory cytokines in early assessment of the prognosis of acute pancreatitis
11. The phylogeny of trypsin-related serine proteases and their zymogens. New methods for the investigation of distant evolutionary relationships
12. Clinical usefulness of polymorphonuclear elastase (PMNE) in predicting the severity of acute pancreatitis. Results of a multicentre study
13. Some aspects of pancreatic disease in the cat
14. Microalbuminuria as predictor of outcome
15. Amelioration of experimental acute pancreatitis with a potent platelet-activating factor antagonist
16. Feline pancreatic disease
17. Acute Pancreatitis
18. Diagnosis of feline pancreatitis and the relevance of trypsin-like immunoreactivity (fTLI)
19. Response to insulin treatment and survival in 104 cats with diabetes mellitus (1985-1995)
20. Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis
21. Trypsinogen activation peptides (TAP) concentrations in the peritoneal fluid of patients and their relation to the presence of histologically confirmed pancreatic necrosis
22. Urinary trypsinogen-2 test strip for acute pancreatitis
23. 1-antitrypsin as diagnostic and prognostic marker of acute pancreatitis: Clinical study in consecutive patients
24. Extracellular phospholipases A2 in relation to systemic inflammatory response syndrome (SIRS) and systemic complications in severe acute pancreatitis
25. Acute necrotizing pancreatitis and acute suppurative pancreatitis in the cat. A retrospective study of 40 cases (1976-1989)
26. Pancreatic pseudocyst associated with chronic-active necrotizing pancreatitis in a cat
27. Development of radioimmunoassays for free tetra-L-aspartyl-L-lysine trypsinogen activation peptides (TAP)
28. Blood concentrations of polymorphonuclear leucocyte elastase and interleukin-6 are indicators for the occurrence of multiple organ failures at the early stage of acute pancreatitis
29. Increased serum trypsinogen 2 and trypsin-2-alpha-1-antitrypsin complex values identify endoscopic retrograde cholangiopancreatography induced pancreatitis with high accuracy
30. Clinical and pathologic changes in experimentally induced acute pancreatitis in cats
31. Dilation of the pancreatic duct: An ultrasonographic finding in acute pancreatitis
32. Protease inhibitors in acute human pancreatitis
33. Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis
34. Sonographic evaluation of the common bile duct in cats
35. Feline pancreatitis
36. Plasma and urinary trypsinogen activation peptide in healthy dogs, dogs with pancreatitis and dogs with other systemic diseases
37. Secretory phospholipase A 2 in patients with infected pancreatic necroses in acute pancreatitis
38. Puolakkainen Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: A multicentre study
39. Ultrasonic features of experimentally induced, acute pancreatitis in the dog
40. Pancreatic disease in the cat
41. Serum trypsin-like immunoreactivity, amylase and lipase in the diagnosis of feline pancreatitis
42. The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis
43. Activation of pancreatic zymogens: Normal activation, premature intrapancreatic activation, protective mechanisms against inappropriate activation
44. Levels of total α-macroglobulin and trypsin-like immunoreactivity are poor indicators of clinical severity in spontaneous canine acute pancreatitis
45. Ultrasonography of the pancreas
46. Acute pancreatitis in the cat
47. Diagnosing acute pancreatitis in the cat
48. Is low proteinuria an early predictor of severity of acute pancreatitis?
49. Current Concepts of the Pathogenesis and Pathophysiology of Acute Pancreatitis in the Dog and Cat
50. Acute pancreatitis in the dog
51. Ante mortem diagnosis of pancreatitis in four cats
52. Feline exocrine pancreatic disease
53. Feline pancreatitis
54. Feline trypsin-like immunoreactivity in feline exocrine pancreatic disease
55. Partial characterisation of feline trypsinogen
56. Serum feline trypsin-like immunoreactivity in cats with exocrine pancreatic insufficiency
57. Evaluation of serum feline trypsin-like immunoreactivity for the diagnosis of pancreatitis in cats
58. Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis
59. Extrahepatic peribiliary glands express alpha-amylase and trypsin in intrahepatic bile ducts and peribiliary glands
60. Pancreatic pseudocysts in 4 dogs and 2 cats: Ultrasonographic and clinicopathologic findings
61. Interleukin 10 prevents necrosis in murine experimental acute pancreatitis
62. Relationship between inflammatory hepatic disease and inflammatory bowel disease, pancreatitis, and nephritis in cats
63. On the protective mechanisms of nitric oxide in acute pancreatitis
64. The laboratory assessment of canine and feline pancreatitis
65. Diagnosis and management of pancreatitis
66. The Pancreas
67. 1-PI) and plasma trypsinogen activation peptides (TAP) in canine experimental pancreatitis
68. C-reactive protein-antiproteases and complement factors as objective markers of severity in acute pancreatitis